Treatment of Colo829 with the S331/704 peptides resulted in decrease in the endogenous Pin1-FOXM1 interaction (Figure 6b), indicating that targeting the Pin1-FOXM1 interaction in melanoma cells is feasible. The gene discussed is FOXM1; the disease is melanoma.